756 related articles for article (PubMed ID: 16100155)
1. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
Hua CC; Chang LC; Chen YC; Chang SC
Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
[TBL] [Abstract][Full Text] [Related]
3. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
4. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
Chung CL; Yeh CY; Sheu JR; Chen YC; Chang SC
Am J Med Sci; 2007 Dec; 334(6):452-7. PubMed ID: 18091367
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.
Chiu CY; Wong KS; Huang JL; Tasi MH; Lin TY; Hsieh SY
Pediatr Infect Dis J; 2008 Aug; 27(8):699-703. PubMed ID: 18664985
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
Lin FC; Chen YC; Chen FJ; Chang SC
Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
Chung CL; Hsiao SH; Hsiao G; Sheu JR; Chen WL; Chang SC
PLoS One; 2013; 8(1):e53169. PubMed ID: 23308155
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
9. [Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells].
Min R; Li S; Wang H; Zhang J; Wang T; Yang Y
Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):599-602. PubMed ID: 11798526
[TBL] [Abstract][Full Text] [Related]
10. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.
Chung CL; Chen YC; Chang SC
Chest; 2003 Apr; 123(4):1188-95. PubMed ID: 12684310
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of cytokine measurement in pleural effusion].
Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355
[TBL] [Abstract][Full Text] [Related]
12. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema.
Yang L; Hu YJ; Li FG; Chang XJ; Zhang TH; Wang ZT
Mediators Inflamm; 2016; 2016():3068103. PubMed ID: 27034588
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
Shojaee S; Voelkel N; Farkas L; de Wit M; Lee HJ
J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
[TBL] [Abstract][Full Text] [Related]
16. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta).
Tietze L; Elbrecht A; Schauerte C; Klosterhalfen B; Amo-Takyi B; Gehlen J; Winkeltau G; Mittermayer C; Handt S
Thromb Haemost; 1998 Feb; 79(2):362-70. PubMed ID: 9493592
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions.
Marchi E; Vargas FS; Acencio MM; Sigrist RMS; Biscaro MDA; Antonangelo L; Teixeira LR; Light RW
Chest; 2012 Jan; 141(1):183-189. PubMed ID: 21680642
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions.
Xirouchaki N; Tzanakis N; Bouros D; Kyriakou D; Karkavitsas N; Alexandrakis M; Siafakas NM
Chest; 2002 Mar; 121(3):815-20. PubMed ID: 11888965
[TBL] [Abstract][Full Text] [Related]
20. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
